Section 32 Announces Two Key Hires

Section 32 has announced the following additions to its team:

• Andy Harrison has joined the firm as Managing Partner. He joins from Alphabet, where he served in leadership roles for both Verily Life Sciences (previously Google Life Sciences) and X (previously GoogleX). Prior to that, he was with Lapis Advisers, where he was Managing Director, Chief Operating Officer. He has also held executive-level roles with Fintan Partners and Northwater Capital.

• Sue Hager has been tapped as Chief Investor Relations and Communications Officer. She is a seasoned life sciences executive with an expertise in communications. She most recently served two Section 32 companies, including: EQRx as Chief Communications Officer and Senior Vice President of Corporate Affairs and Citizenship and Foundation Medicine as Senior Vice President of Corporate Communications and Government Affairs. She has previously held executive-level roles with Myriant, WCG, Targanta Therapeutics, Coley Pharmaceutical Group and Bayer Healthcare.

Section 32 is a venture capital fund investing at the frontiers of technology and healthcare. The San Diego, CA-based firm currently has more than $1 billion in assets under management.